<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.02">
 <iati-activity default-currency="CAD" hierarchy="1" iati-activities:version="2.02" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>XM-DAC-301-2-109052-001</iati-identifier>
  <reporting-org ref="XM-DAC-301-2" type="15">
   <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
   <narrative xml:lang="ES">Centro Internacional de Investigaciones para el Desarrollo</narrative>
   <narrative xml:lang="EN">International Development Research Centre</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Developing a sustainable nanoparticle-based vaccine solution for broilers and layers against E. coli in low and middle-income countries</narrative>
   <narrative xml:lang="FR">&#xC9;laboration d&#x2019;une solution vaccinale durable &#xE0; base de nanoparticules contre E. Coli pour les poulets dans les PFR-PRI</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="FR">L&#x2019;une des maladies les plus courantes dans les &#xE9;levages de volailles est la colibacillose aviaire, qui touche &#xE0; la fois les poulets &#xE0; griller et les poules pondeuses. La bact&#xE9;rie Escherichia coli (E. Coli) pathog&#xE8;ne chez la volaille est responsable de ces infections. Compte tenu des pertes &#xE9;conomiques que peut causer cette pathologie, des taux &#xE9;lev&#xE9;s d&#x2019;antibiotiques sont utilis&#xE9;s &#xE0; la fois pour la pr&#xE9;vention et le traitement. Cependant, les souches d&#x2019;E. Coli qui sont multir&#xE9;sistantes aux antibiotiques rendent souvent ces traitements inefficaces. 

La vaccination est une solution de remplacement qui a le potentiel de fournir une protection efficace et sp&#xE9;cifique et qui induira une r&#xE9;ponse immunitaire. Cela r&#xE9;duira le nombre d&#x2019;infections et, par cons&#xE9;quent, l&#x2019;utilisation d&#x2019;antibiotiques. 

Ce projet appuiera une nouvelle application d&#x2019;un vaccin existant. Le vaccin propos&#xE9;, fabriqu&#xE9; &#xE0; partir de produits biosourc&#xE9;s, est bas&#xE9; sur l&#x2019;am&#xE9;lioration de solutions &#xE0; faible co&#xFB;t qui, ind&#xE9;pendamment, ont d&#xE9;j&#xE0; prouv&#xE9; leur efficacit&#xE9;, leur non-toxicit&#xE9; et leur stabilit&#xE9; dans des climats chauds. La nouvelle application utilise des nanoparticules associ&#xE9;es &#xE0; un extrait compos&#xE9; de diff&#xE9;rentes souches d&#x2019;E.coli. Cette composition imite une infection bact&#xE9;rienne naturelle et entra&#xEE;ne donc le d&#xE9;veloppement d&#x2019;une immunit&#xE9; sp&#xE9;cifique. Compl&#xE9;t&#xE9;e par des adjuvants, elle am&#xE9;liorera l&#x2019;immunit&#xE9; des poulets, offrant ainsi un moyen suppl&#xE9;mentaire de pr&#xE9;venir les maladies opportunistes. Le projet validera le concept et d&#xE9;terminera la meilleure voie d&#x2019;administration pour les poulets &#xE0; griller et les poules pondeuses. 

Une partie de ce projet sera r&#xE9;alis&#xE9;e au Br&#xE9;sil, deuxi&#xE8;me producteur avicole mondial, qui est particuli&#xE8;rement touch&#xE9; par les infections &#xE0; E. coli. Il est mis en &#x153;uvre en collaboration avec Lesaffre International Sarl, un producteur de levure et de produits de fermentation &#xE9;tabli en France, Imunova An&#xE1;lises Biol&#xF3;gicas Ltda, un laboratoire bas&#xE9; au Br&#xE9;sil, et VAXINANO, un fabricant de vaccins install&#xE9; en France.</narrative>
   <narrative xml:lang="EN">One of the most common diseases on poultry farms is avian colibacillosis, which affects both broiler and laying hens. Avian pathogenic Escherichia coli (E. coli) bacteria are responsible for these infections. Given the potential economic losses linked to this pathology, high rates of antibiotics are used for both prevention and treatment. However, strains of E. coli that are multi-resistant to antibiotics often render these treatments ineffective. 

Vaccination is an alternative that has the potential to provide effective and specific protection and will induce an immune response. This will reduce the number of infections and consequently reduce the use of antibiotics. 

This project will support a new application of an existing vaccine technology. The proposed vaccine, made of bio-sourced products, is based on enhancing low-cost solutions that have, on their own, already proven their efficiency, non-toxicity, and stability in hot climate conditions. The new application is based on nanoparticles combined with an extract composed of different strains of E. coli. This mimics a natural bacterial infection and thus leads to the development of specific immunity. Supplemented with adjuvants, it will improve immunity in chickens, offering an additional means to prevent opportunistic diseases. The project will validate the concept and determine the best route of administration in broilers and layers. 

Part of this project will be carried out in Brazil, the world&apos;s second-largest poultry producer, which is particularly affected by E. coli infections. It is being implemented in collaboration with Lesaffre International Sarl, a France-based producer of yeast and fermentation products, Imunova An&#xE1;lises Biol&#xF3;gicas Ltda., a Brazil-based laboratory, and VAXINANO, a vaccine manufacturer based in France.</narrative>
  </description>
  <participating-org role="1" type="10">
   <narrative xml:lang="FR">Canada. Parlement</narrative>
   <narrative xml:lang="EN">Canada. Parliament</narrative>
  </participating-org>
  <participating-org role="3" type="15">
   <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
   <narrative xml:lang="ES">Centro Internacional de Investigaciones para el Desarrollo</narrative>
   <narrative xml:lang="EN">International Development Research Centre</narrative>
  </participating-org>
  <participating-org role="2" type="73">
   <narrative xml:lang="FR">Lesaffre International Sarl</narrative>
  </participating-org>
  <participating-org role="4" type="73">
   <narrative xml:lang="FR">Lesaffre International Sarl</narrative>
  </participating-org>
  <participating-org role="1" type="90">
   <narrative xml:lang="EN">United Kingdom. Department of Health and Social Care</narrative>
  </participating-org>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2019-04-01" type="2"></activity-date>
  <activity-date iso-date="2023-07-01" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
    <narrative xml:lang="EN">International Development Research Centre</narrative>
   </organisation>
   <telephone>(+1) 613-236-6163</telephone>
   <email>info@idrc.ca</email>
   <website>http://www.idrc.ca</website>
   <mailing-address>
    <narrative xml:lang="FR">CP 8500, Ottawa ON Canada, K1G 3H9</narrative>
    <narrative xml:lang="EN">PO Box 8500, Ottawa ON Canada, K1G 3H9</narrative>
   </mailing-address>
  </contact-info>
  <activity-scope code="4"></activity-scope>
  <recipient-country code="BR" percentage="100"></recipient-country>
  <sector code="2" percentage="100" vocabulary="99">
   <narrative xml:lang="EN">Increasing food security</narrative>
   <narrative xml:lang="FR">S&#xE9;curit&#xE9; alimentaire</narrative>
  </sector>
  <sector code="31182" percentage="100" vocabulary="1"></sector>
  <policy-marker code="1" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="2" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="3" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="4" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="5" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="6" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="7" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="8" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="9" significance="0" vocabulary="1"></policy-marker>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-08-08"></transaction-date>
   <value currency="CAD" value-date="2019-08-08">125933.63</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Lesaffre International Sarl</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-08-08"></transaction-date>
   <value currency="CAD" value-date="2019-08-08">125933.63</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Lesaffre International Sarl</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2019-08-08"></transaction-date>
   <value currency="CAD" value-date="2019-08-08">28415</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Lesaffre International Sarl</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2019-08-08"></transaction-date>
   <value currency="CAD" value-date="2019-08-08">57484</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Lesaffre International Sarl</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2019-10-29"></transaction-date>
   <value currency="CAD" value-date="2019-10-29">28415</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Lesaffre International Sarl</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2019-10-29"></transaction-date>
   <value currency="CAD" value-date="2019-10-29">57484</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Lesaffre International Sarl</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-03-31"></transaction-date>
   <value currency="CAD" value-date="2020-03-31">-114969</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Lesaffre International Sarl</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-03-31"></transaction-date>
   <value currency="CAD" value-date="2020-03-31">-56830</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Lesaffre International Sarl</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-03-31"></transaction-date>
   <value currency="CAD" value-date="2020-03-31">114969</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Lesaffre International Sarl</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-03-31"></transaction-date>
   <value currency="CAD" value-date="2020-03-31">56830</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Lesaffre International Sarl</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-08-08"></transaction-date>
   <value currency="CAD" value-date="2019-08-08">254766.37</value>
   <provider-org>
    <narrative xml:lang="EN">United Kingdom. Department of Health and Social Care</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Lesaffre International Sarl</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-08-08"></transaction-date>
   <value currency="CAD" value-date="2019-08-08">254766.37</value>
   <provider-org>
    <narrative xml:lang="EN">United Kingdom. Department of Health and Social Care</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Lesaffre International Sarl</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <conditions attached="1">
   <condition type="2">
    <narrative xml:lang="EN">Grant is conditional on completion of specified terms of reference, receipt of specified deliverables</narrative>
    <narrative xml:lang="FR">La bourse est octroy&#xE9;e &#xE0; condition de respecter le mandat &#xE9;tabli et de livrer les r&#xE9;sultats attendus</narrative>
   </condition>
   <condition type="3">
    <narrative xml:lang="EN">Grant is conditional on periodic submission of a detailed accounting of expenditure of funds received from IDRC accompanied by estimation of budget for the next reporting period</narrative>
    <narrative xml:lang="FR">La bourse est octroy&#xE9;e &#xE0; condition de p&#xE9;riodiquement pr&#xE9;senter une justification d&#xE9;taill&#xE9;e de l&apos;utilisation des fonds vers&#xE9;s par le CRDI ainsi qu&apos;une estimation budg&#xE9;taire de la p&#xE9;riode de rapport suivante</narrative>
   </condition>
  </conditions>
 </iati-activity>
</iati-activities>
